Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Phenylbutyrate-induced G1 arrest and apoptosis in myeloid leukemia cells: structure-function analysis.

DiGiuseppe JA, Weng LJ, Yu KH, Fu S, Kastan MB, Samid D, Gore SD.

Leukemia. 1999 Aug;13(8):1243-53.

PMID:
10450753
2.

Augmentation of phenylbutyrate-induced differentiation of myeloid leukemia cells using all-trans retinoic acid.

Yu KH, Weng LJ, Fu S, Piantadosi S, Gore SD.

Leukemia. 1999 Aug;13(8):1258-65.

PMID:
10450755
4.

Sequence-dependent antitumor effects of differentiation agents in combination with cell cycle-dependent cytotoxic drugs.

Verheul HM, Qian DZ, Carducci MA, Pili R.

Cancer Chemother Pharmacol. 2007 Aug;60(3):329-39. Epub 2007 Jan 26.

PMID:
17256134
5.

1,25-Dihydroxyvitamin D3 induces differentiation of a retinoic acid-resistant acute promyelocytic leukemia cell line (UF-1) associated with expression of p21(WAF1/CIP1) and p27(KIP1).

Muto A, Kizaki M, Yamato K, Kawai Y, Kamata-Matsushita M, Ueno H, Ohguchi M, Nishihara T, Koeffler HP, Ikeda Y.

Blood. 1999 Apr 1;93(7):2225-33.

PMID:
10090931
7.

G(1) Phase growth arrest and induction of p21(Waf1/Cip1/Sdi1) in IB3-1 cells treated with 4-sodium phenylbutyrate.

McGrath-Morrow SA, Stahl JL.

J Pharmacol Exp Ther. 2000 Sep;294(3):941-7.

PMID:
10945844
8.

[5-Aza-2'-deoxycytidine enhances differentiation and apoptosis induced by phenylbutyrate in Kasumi-1 cells].

Hao CL, Tang KJ, Chen S, Xing HY, Wang M, Wang JX.

Zhonghua Zhong Liu Za Zhi. 2005 Mar;27(3):148-51. Chinese.

PMID:
15946563
9.

19-nor vitamin-D analogs: a new class of potent inhibitors of proliferation and inducers of differentiation of human myeloid leukemia cell lines.

Asou H, Koike M, Elstner E, Cambell M, Le J, Uskokovic MR, Kamada N, Koeffler HP.

Blood. 1998 Oct 1;92(7):2441-9.

PMID:
9746784
10.

Relationship between cyclin D1 and p21(Waf1/Cip1) during differentiation of human myeloid leukemia cell lines.

Ullmannová V, Stöckbauer P, Hradcová M, Soucek J, Haskovec C.

Leuk Res. 2003 Dec;27(12):1115-23.

PMID:
12921950
11.

[Effect of phenylbutyrate, a histone deacetylase inhibitor, on differentiation and apoptosis of Kasumi-1 cells].

Hao CL, Tang KJ, Tian Z, Xing HY, Wang M, Wang JX.

Zhonghua Xue Ye Xue Za Zhi. 2003 May;24(5):241-4. Chinese.

PMID:
12859874
13.

Changes in E2F binding after phenylbutyrate-induced differentiation of Caco-2 colon cancer cells.

Wang QM, Feinman R, Kashanchi F, Houghton JM, Studzinski GP, Harrison LE.

Clin Cancer Res. 2000 Jul;6(7):2951-8.

PMID:
10914745
14.

Carnosic acid inhibits proliferation and augments differentiation of human leukemic cells induced by 1,25-dihydroxyvitamin D3 and retinoic acid.

Steiner M, Priel I, Giat J, Levy J, Sharoni Y, Danilenko M.

Nutr Cancer. 2001;41(1-2):135-44.

PMID:
12094616
15.

Apoptosis and tumor remission in liver tumor xenografts by 4-phenylbutyrate.

Svechnikova I, Gray SG, Kundrotiene J, Ponthan F, Kogner P, Ekström TJ.

Int J Oncol. 2003 Mar;22(3):579-88.

PMID:
12579311
16.

Effects of phenylbutyrate on proliferation and apoptosis in human prostate cancer cells in vitro and in vivo.

Melchior SW, Brown LG, Figg WD, Quinn JE, Santucci RA, Brunner J, Thüroff JW, Lange PH, Vessella RL.

Int J Oncol. 1999 Mar;14(3):501-8.

PMID:
10024683
18.

Low-dose genistein induces cyclin-dependent kinase inhibitors and G(1) cell-cycle arrest in human prostate cancer cells.

Shen JC, Klein RD, Wei Q, Guan Y, Contois JH, Wang TT, Chang S, Hursting SD.

Mol Carcinog. 2000 Oct;29(2):92-102.

PMID:
11074606
19.

Sodium 4-phenylbutyrate induces apoptosis of human lung carcinoma cells through activating JNK pathway.

Zhang X, Wei L, Yang Y, Yu Q.

J Cell Biochem. 2004 Nov 1;93(4):819-29.

PMID:
15389886

Supplemental Content

Support Center